Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.
Fast-Acting Novel Depression Tx; Lumryz Label Expanded; GLP-1s for Addiction?
As an adjunctive treatment to antidepressants, investigational SPN-820 — a novel, first-in-class intracellular modulator of mTORC1 that was developed to provide a rapid-onset response —
October 24, 2024